NASDAQ
Amylyx Pharmaceuticals, Inc. (AMLX) has a fcf yield of -10.81% as of Friday, May 29, 2026. This represents a 45.04% increase compared to its 12-month average of -19.67%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.